In the competitive field of Nucleosides, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Nucleosides technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Nucleosides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nucleosides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nucleosides industry

EP3438116Labelled NucleotidesILLUMINA CAMBRIDGE LIMITEDNov 17, 2021LATVIA MGI TECH SIA
EP2399588Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseMERCK SHARP & DOHME LLCJan 7, 2021GILEAD SCIENCES, INC.
EP2752488Antisense DesignROCHE INNOVATION CENTER COPENHAGEN A/SNov 12, 2020IONIS PHARMACEUTICALS, INC.
EP3363809Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE LIMITEDAug 24, 2020LATVIA MGI TECH SIA
EP3587433Modified NucleotidesILLUMINA CAMBRIDGE LIMITEDAug 24, 2020LATVIA MGI TECH SIA
EP3002289Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE LIMITEDApr 29, 2020MGI TECH HONG KONG CO., LIMITED
EP1633766Modified Fluorinated Nucleoside AnaloguesPHARMASSET, INC.Dec 5, 2019GILLARD, RICHARD EDWARD
EP3147292Labelled NucleotidesILLUMINA CAMBRIDGE LIMITEDJun 26, 2019HOFFMANN EITLE
EP2955190Chemical CompoundsNUCANA BIOMED LIMITEDDec 17, 2018GILEAD SCIENCES, INC.
EP3002289Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE LIMITEDNov 28, 2018HOFFMANN EITLE

To stay ahead in the competitive Nucleosides industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nucleosides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2682397Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES, INC.5
EP2338893Dec 25, 2019Labelled NucleotidesILLUMINA CAMBRIDGE LIMITED2
EP2896397Oct 7, 2020Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose TransporterMITSUBISHI TANABE PHARMA CORPORATION2
EP3002289Feb 28, 2018Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE LIMITED2
EP3147292Sep 26, 2018Labelled NucleotidesILLUMINA CAMBRIDGE LIMITED1
EP3363809Apr 8, 2020Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE LIMITED1
EP3438116Feb 17, 2021Labelled NucleotidesILLUMINA CAMBRIDGE LIMITED1
EP1633766Mar 6, 2019Modified Fluorinated Nucleoside AnaloguesPHARMASSET, INC.1
EP3587433Apr 22, 2020Modified NucleotidesILLUMINA CAMBRIDGE LIMITED1
EP2399588Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseMERCK SHARP & DOHME CORP.1